This article was originally published in The Tan Sheet
The biosciences firm enters a licensing and distribution agreement with Solgar Vitamin and Herb to develop Nutrigenomx, a proprietary dietary supplement system tailored to an individual's genetic makeup. According to a Dec. 4 release, Leonia, N.J.-based Solgar will market the brand in its network of health and natural food retailers in North America beginning in 2008. The line will use Jersey City, N.J.-based GeneLink's Nutritional System...
You may also be interested in...
Just five weeks before the US election, a Medtech Insight analysis shows medical device companies are spending more on Democrat Joe Biden’s campaign than on Republican Donald Trump’s.
Denmark’s Orphazyme has raised more funds to market its lead product, the heat shock protein amplifier, arimoclomol, in the US and Europe, and to evaluate the compound for other lysosomal storage and neurodegenerative disorders.
Pacific Biosciences of California and Aziyo Biologics both acquire new finance chiefs; Illumina hires a new chief marketing officer; WishBone Medical president moves over to take helm at Electromedical Products International; and more.